Phase III study comparing tacrolimus (FK506) with cyclosporine (CSP) for prophylaxis of acute graft-versus-host disease (GVHD) after marrow transplantation from unrelated donors.

被引：0
|
作者：
Nash, RA
Antin, J
Karanes, C
Fay, J
Avalos, B
Yeager, AM
Przepiorka, D
Davies, S
Petersen, F
Buell, D
Fitzsimmons, W
Bartels, P
Hansen, J
Anasetti, C
Storb, R
Ratanatharathorn, V
机构：
[1] FRED HUTCHINSON CANC RES CTR,BOSTON,MA
[2] BAYLOR UNIV,MED CTR,WAYNE STATE HOSP,WACO,TX 76798
[3] OHIO STATE UNIV,COLUMBUS,OH 43210
[4] EMORY UNIV,ATLANTA,GA 30322
[5] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
[6] UNIV UTAH,SALT LAKE CITY,UT 84112
[7] UNIV MICHIGAN,ANN ARBOR,MI 48109
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2499 / 2499
页数：1
相关论文
共 50 条
  • [1] Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation
    A Hiraoka
    Y Ohashi
    S Okamoto
    Y Moriyama
    T Nagao
    Y Kodera
    A Kanamaru
    H Dohy
    T Masaoka
    Bone Marrow Transplantation, 2001, 28 : 181 - 185
  • [2] Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation
    Hiraoka, A
    Ohashi, Y
    Okamoto, S
    Moriyama, Y
    Nagao, T
    Kodera, Y
    Kanamaru, A
    Dohy, H
    Masaoka, T
    BONE MARROW TRANSPLANTATION, 2001, 28 (02) : 181 - 185
  • [3] Phase III study comparing tacrolimus (PROGRAF(R), FK506) with cyclosporine for graft-versus-host disease (GVHD) prophylaxis after HLA-identical sibling bone marrow transplantation (BMT).
    Ratanatharathorn, V
    Nash, RA
    Devine, SM
    Przepiorka, D
    Klein, JL
    Weisdorf, DJ
    Fay, JW
    Nademanee, AP
    Antin, JH
    Karanes, C
    Avalos, BR
    Christiansen, NP
    VanderJagt, RH
    Herzig, RH
    Litzow, MR
    Wolff, SN
    Longo, WR
    Petersen, FB
    Buell, DN
    Maher, RM
    Fitzsimmons, WE
    Wingard, JR
    BLOOD, 1996, 88 (10) : 1826 - 1826
  • [4] Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors
    Nash, RA
    Antin, JH
    Karanes, C
    Fay, JW
    Avalos, BR
    Yeager, AM
    Przepiorka, D
    Davies, S
    Petersen, FB
    Bartels, P
    Buell, D
    Fitzsimmons, W
    Anasetti, C
    Storb, R
    Ratanatharathorn, V
    BLOOD, 2000, 96 (06) : 2062 - 2068
  • [5] Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation
    Ratanatharathorn, V
    Nash, RA
    Przepiorka, D
    Devine, SM
    Klein, JL
    Weisdorf, D
    Fay, JW
    Nademanee, A
    Antin, JH
    Christiansen, NP
    van der Jagt, R
    Herzig, RH
    Litzow, MR
    Wolff, SN
    Longo, WL
    Petersen, FB
    Karanes, C
    Avalos, B
    Storb, R
    Buell, DN
    Maher, RM
    Fitzsimmons, WE
    Wingard, JR
    BLOOD, 1998, 92 (07) : 2303 - 2314
  • [6] FK506 TO PREVENT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC MARROW TRANSPLANTATION (AMT) USING UNRELATED MARROW DONORS (UMD)-A PHASE-II STUDY
    FAY, JW
    COLLINS, RH
    PINEIRO, LA
    NEMUNAITIS, JJ
    ARO, R
    FITZSIMMONS, W
    BLOOD, 1993, 82 (10) : A420 - A420
  • [7] FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors
    Nash, RA
    Pineiro, LA
    Storb, R
    Deeg, HJ
    Fitzsimmons, WE
    Furlong, T
    Hansen, JA
    Gooley, T
    Maher, RM
    Martin, P
    McSweeney, PA
    Sullivan, KM
    Anasetti, C
    Fay, JW
    BLOOD, 1996, 88 (09) : 3634 - 3641
  • [8] Prevention of graft-versus-host (GVHD) after unrelated marrow transplantation therapy (UMT) using tacrolimus (FK506) and prednisone.
    Fay, JW
    Agura, E
    Collins, R
    Pineiro, L
    BLOOD, 1996, 88 (10) : 1660 - 1660
  • [9] FK506 IN COMBINATION WITH METHOTREXATE (MTX) FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM PHENOTYPICALLY HLA-IDENTICAL UNRELATED DONORS
    NASH, RA
    MCSWEENEY, PA
    STORB, R
    GOOLEY, T
    FURLONG, T
    APPELBAUM, F
    DEEG, HJ
    DONEY, K
    MARTIN, P
    SULLIVAN, K
    WITHERSPOON, R
    ZAGER, RA
    HANSEN, JA
    ANASETTI, C
    BLOOD, 1994, 84 (10) : A394 - A394
  • [10] Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
    G Yanik
    JE Levine
    V Ratanatharathorn
    R Dunn
    J Ferrara
    RJ Hutchinson
    Bone Marrow Transplantation, 2000, 26 : 161 - 167
12345